AtaiBeckley To Participate in Upcoming Investor Conferences

Rhea-AI Summary

AtaiBeckley (NASDAQ: ATAI) said its CEO Srinivas Rao, M.D., Ph.D., and VP of Investor Relations Jason Awe, Ph.D., will attend investor conferences in March 2026 with fireside chats and one-on-one meetings.

Events: TD Cowen (Boston) on March 4 with a fireside chat 11:50am–12:20pm EST; Jefferies Biotech on March 10 (one-on-ones) in Miami; Leerink (Miami) on March 11 with a fireside chat 8:00am–8:30am EST. Live webcasts of the fireside chats will be available on the company's investor site and archived for at least 30 days.

Market Reaction

+6.72% $3.81

15m delay 10 alerts

+6.72% Since News

$3.81 Last Price

$3.65 $3.88 Day Range

+$87M Valuation Impact

$1.38B Market Cap

0.4x Rel. Volume

Following this news, ATAI has gained 6.72%, reflecting a notable positive market reaction. Our momentum scanner has triggered 10 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $3.81. This price movement has added approximately $87M to the company's valuation.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced that Srinivas Rao, M.D., Ph.D., Co-Founder and Chief Executive Officer, and Jason Awe, Ph.D., Vice President of Investor Relations, will participate in fireside chats and host one-on-one meetings at the following investor conferences in March.

TD Cowen 46th Annual Health Care Conference

• Format: Fireside chat, Wednesday, March 4, from 11:50am – 12:20pm EST and one-on-one meetings
• Location: Boston, Massachusetts
  
  

Jefferies 2026 Biotech on the Beach

• Format: One-on-one meetings only, Tuesday, March 10
• Location: Miami, Florida
  
  

Leerink Global Healthcare Conference

• Format: Fireside chat, Wednesday, March 11, from 8:00am – 8:30am EST and one-on-one meetings
• Location: Miami, Florida
  
  

Live webcasts of the fireside chats will be available on the investor section of the AtaiBeckley website, under Events. The archived webcasts will be available for at least 30 days after the event.

About AtaiBeckley Inc.

AtaiBeckley is a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments. AtaiBeckley’s pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder. BPL-003 is in Phase 3 planning, VLS-01 and EMP-01 are in Phase 2 clinical development. The Company is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for opioid use disorder and TRD. These programs aim to create breakthroughs in mental health through transformative interventional psychiatry therapies that can integrate seamlessly into healthcare systems.

For the latest updates and to learn more about the AtaiBeckley mission, visit www.ataibeckley.com or follow the Company on LinkedIn and on X.

Investor and Media Relations
Investors:
Jason Awe, PhD
VP, Investor Relations
IR@ataibeckley.com

Media:
Charlotte Chorley

Associate Director, Communications
PR@ataibeckley.com

FAQ

When will AtaiBeckley (ATAI) present at the TD Cowen 46th Annual Health Care Conference?

AtaiBeckley will present a fireside chat on March 4, 2026 from 11:50am–12:20pm EST. According to the company, the session is in Boston and will include one-on-one investor meetings the same day.

How can investors watch ATAI fireside chats for the March 2026 conferences?

Investors can watch live webcasts on the AtaiBeckley investor website during each fireside chat. According to the company, archived webcasts will remain available on the site for at least 30 days after each event.

What is AtaiBeckley (ATAI) scheduled to do at Jefferies Biotech on March 10, 2026?

AtaiBeckley will hold one-on-one investor meetings only at Jefferies Biotech on March 10, 2026 in Miami. According to the company, no public fireside chat is scheduled for that specific event.

Who from AtaiBeckley (ATAI) will participate in the March 2026 conference events?

Srinivas Rao, M.D., Ph.D., CEO, and Jason Awe, Ph.D., VP of Investor Relations, will participate in fireside chats and one-on-one meetings. According to the company, both executives will attend the listed March investor events.

How long will the AtaiBeckley (ATAI) Leerink fireside chat on March 11, 2026 run?

The Leerink fireside chat is scheduled for March 11, 2026 from 8:00am–8:30am EST, a 30-minute session. According to the company, the event will be in Miami and a webcast will be posted on the investor site.